Therapeutic TriMix / mRNA based Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral Therapy
The iHIVARNA project is an immunogen-focused research project that brings together the expertise of a number of European groups in dendritic cells targeting, rational design of immunogens, mRNA manufacturing and immuno-virological monitoring with the ultimate objective of finding an alternative therapy to cART for life, a hot topic of the HIV field. iHIVARNA will assess through the implementation of two clinical trials safety, efficacy and immunogenicity of a novel HIV vaccine candidate.
[separator size=’small’ margin=’small’/]
iHIVARNA project website